Journal articleNPJ Precis Oncol2025
Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer.
- Journal
- NPJ Precis Oncol
- Published
- 22 August 2025
- Citations
- 9
- Type
- Article
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 9
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Targeting Mucin and EGFR Axis in Pancreatic Cancer R01CA183459↗
- Targeted Radiation Therapy for Pancreatic Cancer R01CA195586↗
- Rac1 GTPase in tumorigenesis and progression of pancreatic cancer R01CA206444↗
- Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia R01CA210637↗
- Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer R01CA247471↗
- Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer R01CA290859↗
- Targeting LIF/LIFR in pancreatic cancer R44CA235991↗
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma U01CA200466↗